-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
Sign up for news updates
Meeting News
-
Increasing Evidence Demonstrates the Usefulness of ctDNA
LALCA participants recap how the field of liquid biopsy continues to grow—from new biomarkers to new frontiers in early cancer detection.
-
Education Award Recipients Recognized at Latin America Conference
During the Closing Ceremony, five early-career, trainee, or resident investigators were honored for presenting at LALCA 2023.
-
Latin America Conference Attendees Gather Face-to-Face for First Time Since 2019
As LALCA 2023 gets under way in Montevideo, Uruguay, hear from chairs Drs. Luis Ubillos, Mario Varangot, Clarissa Mathias, and Carlos Barrios about the science that will be discussed.
-
Despite Evidence of Benefit, Developing Countries Often Lack Routine Lung Cancer Screening Practices
Expert panel to discuss challenges and opportunities for increasing LDCT screening in Latin America during LALCA 2023.
-
Presidential Symposium Features Best of Abstract Submissions
Highlighted studies explore the association of TP53 mutations with inferior prognosis in NSCLC patients of African ancestry, the possibilities for next-generation sequencing to guide therapy, and the use of a 12-gene expression panel to predict treatment benefit.
-
Passing of The Baton—On the Death of Patient Research Advocates
Patient Perspective: We honor those we’ve lost by continuing their advocacy work, patient advocate Angus Pratt says.
-
New Screening Approach Needed to Detect Lung Cancer in Patients who Never Smoked
During ACLC 2022, Dr. Gee-Chen Chang made the case for moving beyond smoking history to identify at-risk patients and shared an alternative risk predication model that compared favorably against NLST and NELSON.
-
Palliative Care Benefits Vary Depending on Providers, Timing
In the first of a series of articles on supportive care in lung cancer, Dr. David Hui outlines the needs and reviews evidence-based best practices.
-
In Brief for Dec. 7, 2022
Learn how new guidance from the UK’s National Institutes for Health Care Excellence addresses an unmet clinical need for patients with EGFR+ NSCLC with exon 20 insertion and stay up to date on the latest meeting news from IASLC.
-
Targeted Therapies Expanding for MET Dysregulation in NSCLC
During ACLC 2022, Dr. Noemi Reguart reviewed the data for MET-targeting TKIs and monoclonal antibodies for patients with METex14 skipping mutations, MET amplification, and MET overexpression.
View ILCN Archives
Provider Resources
Popular Articles